country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Cat. No.: HY-144132

Copy Link Print Information

αβ-Tubulin-IN-1

αβ-Tubulin-IN-1 is a potent and orally active αβ-Tubulin inhibitor. αβ-Tubulin-IN-1 induces cell cycle arrest at G2/M and efficient apoptosis. αβ-Tubulin-IN-1 inhibits tumor cell migration and Metastasis. αβ-Tubulin-IN-1 shows significant antitumor efficacy in a dose dependent manner.

For research use only. We do not sell to patients.

CAS No.: 2478584-74-4
Formula: C₂₅H₁₉N₃O₃
Molecular Weight:409.44

Storage:

Please store the product under the recommended conditions in the Certificate of Analysis.

Data Sheet (280 KB)

αβ-Tubulin-IN-1 Chemical Structure

CAS No.: 2478584-74-4

Price

Stock

Quantity

Amount: USD 0.00

* Please select Quantity before adding items.

Use of MCE Products

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biological Activity
- Description
- IC₅₀ & Target
- Cellular Effect
- In Vitro
- In Vivo
Chemical Information
Purity & Documentation
References
Calculators
Help & FAQs
Classifications
Bioz

Biological Activity

Description

IC₅₀ & Target

αβ-Tubulin^[1]

Cellular Effect

Cell Line	Type	Value	Description	References
A2780/Taxol	IC₅₀	13.1 nM Compound: 12b	Cytotoxicity in human A2780T assessed as inhibition in cell growth measured after 24 hrs by MTT assay Cytotoxicity in human A2780T assessed as inhibition in cell growth measured after 24 hrs by MTT assay	[PMID: 35084853]
A2780S	IC₅₀	16.4 nM Compound: 12b	Cytotoxicity in human A2780S assessed as inhibition in cell growth measured after 24 hrs by MTT assay Cytotoxicity in human A2780S assessed as inhibition in cell growth measured after 24 hrs by MTT assay	[PMID: 35084853]
A2780S	IC₅₀	8 nM Compound: 12b	Antiproliferative activity against human A2780S cells assessed as reduction in cell viability measured after 24 hrs by MTT assay Antiproliferative activity against human A2780S cells assessed as reduction in cell viability measured after 24 hrs by MTT assay	[PMID: 35084853]
A549	IC₅₀	60.1 nM Compound: 12b	Cytotoxicity in human A549 assessed as inhibition in cell growth measured after 24 hrs by MTT assay Cytotoxicity in human A549 assessed as inhibition in cell growth measured after 24 hrs by MTT assay	[PMID: 35084853]
A549/TR	IC₅₀	63.8 nM Compound: 12b	Cytotoxicity in human A549T assessed as inhibition in cell growth measured after 24 hrs by MTT assay Cytotoxicity in human A549T assessed as inhibition in cell growth measured after 24 hrs by MTT assay	[PMID: 35084853]
HeLa	IC₅₀	5 nM Compound: 12b	Antiproliferative activity against human HeLa cells assessed as reduction in cell viability measured after 24 hrs by MTT assay Antiproliferative activity against human HeLa cells assessed as reduction in cell viability measured after 24 hrs by MTT assay	[PMID: 35084853]
MCF7	IC₅₀	11.3 nM Compound: 12b	Cytotoxicity in human MCF7 assessed as inhibition in cell growth measured after 24 hrs by MTT assay Cytotoxicity in human MCF7 assessed as inhibition in cell growth measured after 24 hrs by MTT assay	[PMID: 35084853]
MCF7	IC₅₀	9 nM Compound: 12b	Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay	[PMID: 35084853]
NCI/ADR-RES	IC₅₀	13.5 nM Compound: 12b	Cytotoxicity in human NCI-ADR-RES assessed as inhibition in cell growth measured after 24 hrs by MTT assay Cytotoxicity in human NCI-ADR-RES assessed as inhibition in cell growth measured after 24 hrs by MTT assay	[PMID: 35084853]
NCI-H460	IC₅₀	14 nM Compound: 12b	Antiproliferative activity against human NCI-H460 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay Antiproliferative activity against human NCI-H460 cells assessed as reduction in cell viability measured after 24 hrs by MTT assay	[PMID: 35084853]
Raji	IC₅₀	13 nM Compound: 12b	Antiproliferative activity against human Raji cells assessed as reduction in cell viability measured after 24 hrs by MTT assay Antiproliferative activity against human Raji cells assessed as reduction in cell viability measured after 24 hrs by MTT assay	[PMID: 35084853]

In Vitro

αβ-Tubulin-IN-1 (compound 12 b) (0, 0.5, 1, 5, 10, 50 µM; 16 h) promotes αβ-tubulin degradation in a concentration-dependent manner in Hela and K562 (0-10 µM) cells^[1].
αβ-Tubulin-IN-1 exhibits potent cytotoxic activity toward sensitive cells and resistant cells^[1].
αβ-Tubulin-IN-1 (0-300 nM; 48 h) induces cell cycle arrest at G2/M and efficient apoptosis in A2780S and A2780T cells^[1].
αβ-Tubulin-IN-1 (0, 1.25, 2.5, 5, 10 nM; 24, 48 h) inhibits tumor cell migration and Metastasis with the inhibition rate of 76.21% and 85.07% for 24 , 48 h in human umbilical vein endothelial cells (HUVEC)^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Proliferation Assay^[1]

Cell Line:

Hela, A2780S, MCF-7, Raji, H460 cells
Concentration:

0-500 nM
Incubation Time:

24 h
Result:

Showed anti-proliferative activity with IC₅₀s of 5, 8, 9,13, 14 nM for Hela, A2780S, MCF-7, Raji, H460 cells, respectively.

Western Blot Analysis^[1]

Cell Line:

HeLa cells
Concentration:

10 µM
Incubation Time:

16 h
Result:

Remarkably promoted tubulin degradation by binding to the colchicine site, and the degradation process relied on the ubiquitin−proteasome pathway.

Cell Viability Assay^[1]

Cell Line:

A2780S, A2780T, A549, A549T, MCF7, MCF7/ADR cells
Concentration:
Incubation Time:

24 h
Result:

Exhibited potent cytotoxic activity with IC₅₀s of 16.4, 13.1, 60.1, 63.8, 11.3, 13.5 nM for A2780S, A2780T, A549, A549T, MCF7, MCF7/ADR cells, respectively.

Cell Cycle Analysis^[1]

Cell Line:

A2780S (PTX-sensitive), A2780T ( PTX-resistant) cells
Concentration:

0, 3, 10, 30, 100, 300 nM
Incubation Time:

48 h
Result:

Induced cell cycle arrest at G2/M phase with the the percentages of A2780S and A2780T cells were 55.10%, 72.18% at 100 nM, and 79.54%, 72.89% at 300 nM.

Apoptosis Analysis^[1]

Cell Line:

A2780S, A2780T cells
Concentration:

0, 3, 10, 30, 100, 300 nM
Incubation Time:

48 h
Result:

Induced cell apoptosis with the total numbers of late apoptotic cells were 3.7%, 25.2%, 30.6% at 30,100, and 300 nM, and 5.2% % late apoptotic cells in control.

In Vivo

αβ-Tubulin-IN-1 (5 mg/kg; i.v., p.o.) shows intravenous and oral administration approaches are available in vivo^[1].
αβ-Tubulin-IN-1 (10, 20, 40 mg/kg; i.v.; 3 times a week for 2-4 weeks) shows significant antitumor efficacy in a dose dependent manner^[1].
Pharmacokinetic Parameters of αβ-Tubulin-IN-1 in rats^[1].

route	i.v.	p.o.
dose (mg/kg)	5	5
T_1/2 (h)	3.57±1.10	4.42±1.90
CL (L/h/kg)	1.52±0.39	5.06±1.70
V_ss (L/kg)	8.08±4.19	35.26±25.76
AUC_0-∞ (µg/mL·h)	3448.81±782.66	1058.74±285.62
C_max (µg/L)	2601.47±444.20	189.29±119.02
F (%)		30.70

Rats, 5 mg/kg for i.v., 5 mg/kg for p.o.^[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model:

Rats^[1]
Dosage:

5 mg/kg
Administration:

I.v. or p.o.
Result:

Showed oral bioavailability (F=30.70%) with the T1/2 values for intravenous and oral administration approaches are 3.57 h and 4.42 h, respectively.

Animal Model:

5-6weeks female Balb/C and athymic nude mice (A2780S and A2780T Xenograft) Models^[1]
Dosage:

10, 20, 40 mg/kg for i.v., 40 mg/kg for p.o.
Administration:

I.v.; 3 times a week for 2-4 weeks
Result:

Showed significant antitumor efficacy with tumor growth inhibition (TGI) of 66.06%, 71.47% and 92.41% at 10, 20 and 40 mg/kg in A2780S xenograft nude mice model, and 26.94%, 37.2%, 75.73% at 10, 20 and 40 mg/kg in PTX-resistant A2780T xenograft model for i.v. injection, did not show an acceptable antitumor efficacy with 34.93% of TGI at the 40 mg/kg for p.o..

Chemical Information

CAS No. 2478584-74-4
Molecular Weight 409.44
Formula C₂₅H₁₉N₃O₃
SMILES

C(N1)(C=NC(NCC2=CC=CC(OC3=CC=C(OCO4)C4=C3)=C2)=C5)=C5C6=C1C=CC=C6
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation

Select Batch:

Purity: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (280 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

References

[1]. Li Y, et al. Structure-Based Design and Synthesis of N-Substituted 3-Amino-β-Carboline Derivatives as Potent αβ-Tubulin Degradation Agents. J Med Chem. 2022 Feb 10;65(3):2675-2693. [Content Brief]

Calculators

Molarity Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Concentration Concentration

Volume Volume

Molecular Weight Molecular Weight

Dilution Calculator

Concentration _(start) × Volume _(start) = Concentration _(final) × Volume _(final)

Concentration _(start) Concentration _(start)

Volume _(start) Volume _(start)

Concentration _(final) Concentration _(final)

Volume _(final) Volume _(final)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

Get Quote In-stock

Other size

Get Quote